Clinical trials: Acute Type A Aortic Dissection With Arch Involvement
Acute Type A Aortic Dissection With Arch Involvement, Cardiopulmonary Bypass
Hemoperfusion in Acute Type A Aortic Dissection Patients Undergoing Aortic Arch Operation (HPAO)
This study is a single-center, randomized, controlled, double-blind clinical trial. The main purpose of this study is to evaluate if hemoperfusion is sufficient to improve the prognosis of acute type A aortic dissection patients…
- Conditions
- Acute Type A Aortic Dissection With Arch Involvement, Cardiopulmonary Bypass, Deep Hypothermic Circulatory Arrest
- Trial name
- HPAO (NCT04007484)
- Testing
- Hemoperfusion
- Where
- China
- Volunteers
- 88 people
- Sponsor
- The Second Hospital of Nanjing Medical University